PresseMitteilungen CategoriesNewBiotechCategory / Pharmaceuticals & Biotech / Biotech Dynavax Appoints David Happel Vice President, Global Sales and Marketing BERKELEY, CA: ... Alere Secures Final Option Period on Miraculins' Preeclampsia Technology WINNIPEG, MANITOBA: Research and Development Program to Focus on Select Set of Biomarkers ... TiGenix Enrolls First Patients in Pivotal Phase III Trial With Lead Product Cx601 in Perianal Fistulas LEUVEN, BELGIUM: ADMIRE CD Trial to Enroll Over 200 Patients in 46 Centers Across 8 Countries ... Peregrine to Report Fourth Quarter and Fiscal Year 2012 Financial Results After Market Close on July 16, 2012 TUSTIN, CA: ... Theratechnologies to Announce Financial Results for Second Quarter of 2012 MONTREAL, QUEBEC: ... Dynavax to Present at the 7th Annual JMP Securities Healthcare Conference BERKELEY, CA: ... Mobius Therapeutics(TM) Commences First Shipments of New Glaucoma Drug ST. LOUIS, MO: Mitosol(R) to Fill Immediate Clinical Need in Glaucoma Surgery ... Ceapro Announces Re-Election of Board, Adoption of Amended Stock Option Plan and Appointment of President and CEO EDMONTON, ALBERTA: ... MethylGene to Present at the Seventh Annual JMP Securities Healthcare Conference MONTREAL, CANADA: ... Kadmon Corporation to Present at the JMP Securities Healthcare Conference NEW YORK, NY: ... Patent Allowances Received for Hydrogen Sulphide-Preventing Wine Yeasts VANCOUVER, BRITISH COLUMBIA: ... Titan Completes Preclinical Study of a Continuous, Dopamine Agonist Treatment for Parkinson's Disease SOUTH SAN FRANCISCO, CA: ... Audeo Oncology, Inc. Files Registration Statement for Proposed Initial Public Offering SAN FRANCISCO, CA: ... AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference BOTHELL, WA: Webcast Accessible via AVI Website ... MindUp BioResearch (HIRU) Shareholder Corporate Update BELGRADE, SERBIA: ... Pharma-Bio Industry Sees $6.8 Billion in Capital Investments From 214 Construction Projects Launched in First-Half 2012, an Industrial Info News Alert SUGAR LAND, TX: ... Peregrine to Present at JMP Securities Healthcare Conference July 12, 2012 at 9:30 AM EDT TUSTIN, CA: ... Biotie Completes Enrollment in Phase 2b Trial of Tozadenant in Parkinson's Disease TURKU, FINLAND: ... Warnex Announces Refinancing LAVAL, QUEBEC: ... Functional Technologies Appoints International Food Industry Executive to Advisory Board VANCOUVER, BRITISH COLUMBIA: ... Page 190 von 247: 1 « .. 189 190 191 192 193 194 195 196 197 198 .. » 247